LAMEDITECH Co., Ltd.
Research LAMEDITECH Co., Ltd. (462510.KQ) on Bullrun: market cap KRW 27.29B. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker462510.KQ
- ExchangeKQ
- CountrySouth Korea
- SectorHealthcare
- IndustryMedical Devices
- CurrencyKRW
- Market capKRW 27.29B
- Financial periodQ2 2026
- RevenueKRW 1.13B
- Net income-KRW 828.80M
- Free cash flow-KRW 1.49B
- Gross margin36.1%
Valuation Snapshot
latest market cap is KRW 27.29B.
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | KRW 27.29B | n/a | n/a | n/a |
Dividend history
About LAMEDITECH Co., Ltd.
Lameditech Co., Ltd. develops, manufactures, and sells laser blood samplers and medical devices in South Korea. It offers laser lancing devices under the HandyRay-Lite and HandyRay names; HandyRay-Pro, a professional laser blood collection device for hospitals and medical institutions; CAREVEAM, a device designed for the treatment of various skin diseases with its 308nm excimer light system;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is LAMEDITECH Co., Ltd.'s market cap?
LAMEDITECH Co., Ltd.'s market capitalization is KRW 27.29B.
What does LAMEDITECH Co., Ltd. do?
Lameditech Co., Ltd. develops, manufactures, and sells laser blood samplers and medical devices in South Korea. It offers laser lancing devices under the HandyRay-Lite and HandyRay names; HandyRay-Pro, a professional laser blood collection device for hospitals and medical institutions; CAREVEAM, a device designed for the treatment of various skin diseases with its 308nm excimer light system; and Ray-Vet, a UVB light irradiation therapy system designed to treat inflammatory skin diseases and various auto-immune diseases in pets and animals.